Jyoti D. Patel on the Progress of Immunotherapy in NSCLC

A friend of mine is strong in her faith and is living well with a stage 4 cancer diagnosis. She is someone I look up to in these matters.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

During summer 2024, there have been many changes made in the non-small cell lung cancer and small cell lung cancer spaces. Here are four top news stories.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

When I started receiving chemotherapy for stage 3B lung cancer, I initially felt hopeless.

I used to think that having lung cancer canceled all of my life's plans, but I realized I shouldn't give it that much power.